PCOS is a widely studied syndrome associated with insulin resistance, for which insulin-sensitizing factors have been proposed as putative treatments to improve the hyperinsulinemia-related dysfunction of ovarian response to endogenous gonadotropins. This evidence concerns the gene INS and polycystic ovary syndrome.